California Public Employees Retirement System’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.8M Buy
173,369
+6,504
+4% +$817K 0.01% 590
2025
Q1
$18.5M Sell
166,865
-286,226
-63% -$31.7M 0.01% 620
2024
Q4
$61.8M Sell
453,091
-9,056
-2% -$1.24M 0.04% 339
2024
Q3
$53.2M Sell
462,147
-22,873
-5% -$2.64M 0.04% 386
2024
Q2
$66.8M Sell
485,020
-95,597
-16% -$13.2M 0.05% 320
2024
Q1
$80.1M Sell
580,617
-6,333
-1% -$873K 0.06% 301
2023
Q4
$77.3M Sell
586,950
-5,035
-0.9% -$663K 0.06% 295
2023
Q3
$66.6M Buy
591,985
+4,755
+0.8% +$535K 0.06% 309
2023
Q2
$55.4M Sell
587,230
-16,496
-3% -$1.56M 0.05% 348
2023
Q1
$61.1M Sell
603,726
-27,808
-4% -$2.81M 0.05% 322
2022
Q4
$75.4M Sell
631,534
-18,250
-3% -$2.18M 0.06% 302
2022
Q3
$69M Buy
649,784
+4,280
+0.7% +$455K 0.06% 299
2022
Q2
$62.9M Sell
645,504
-10,071
-2% -$982K 0.06% 295
2022
Q1
$61.5M Buy
655,575
+26,693
+4% +$2.5M 0.05% 340
2021
Q4
$53.6M Buy
628,882
+418,990
+200% +$35.7M 0.04% 403
2021
Q3
$20.1M Sell
209,892
-1,134
-0.5% -$109K 0.02% 660
2021
Q2
$20.5M Sell
211,026
-11,926
-5% -$1.16M 0.02% 678
2021
Q1
$21.7M Sell
222,952
-3,136
-1% -$305K 0.02% 652
2020
Q4
$21.7M Buy
226,088
+14,882
+7% +$1.43M 0.02% 626
2020
Q3
$20.3M Buy
211,206
+5,200
+3% +$500K 0.02% 570
2020
Q2
$25.1M Buy
206,006
+1,052
+0.5% +$128K 0.02% 483
2020
Q1
$17.7M Buy
204,954
+13,529
+7% +$1.17M 0.02% 508
2019
Q4
$20.6M Buy
191,425
+40,025
+26% +$4.3M 0.02% 600
2019
Q3
$13.6M Buy
151,400
+30,900
+26% +$2.78M 0.01% 721
2019
Q2
$10.2M Sell
120,500
-3,600
-3% -$304K 0.01% 746
2019
Q1
$10.9M Sell
124,100
-42,576
-26% -$3.75M 0.01% 754
2018
Q4
$11.9M Sell
166,676
-12,400
-7% -$885K 0.02% 680
2018
Q3
$22M Buy
179,076
+14,350
+9% +$1.76M 0.03% 563
2018
Q2
$16.2M Sell
164,726
-23,398
-12% -$2.3M 0.02% 662
2018
Q1
$15.6M Sell
188,124
-4,011
-2% -$333K 0.02% 684
2017
Q4
$14.9M Buy
192,135
+10,235
+6% +$794K 0.02% 711
2017
Q3
$11.1M Buy
181,900
+2,600
+1% +$159K 0.02% 809
2017
Q2
$8.25M Buy
179,300
+3,900
+2% +$179K 0.01% 950
2017
Q1
$7.6M Sell
175,400
-7,600
-4% -$329K 0.01% 997
2016
Q4
$7.08M Sell
183,000
-9,400
-5% -$364K 0.01% 1042
2016
Q3
$9.74M Sell
192,400
-43,700
-19% -$2.21M 0.02% 850
2016
Q2
$10.7M Sell
236,100
-6,200
-3% -$282K 0.02% 799
2016
Q1
$9.58M Buy
242,300
+58,100
+32% +$2.3M 0.02% 844
2015
Q4
$10.4M Buy
184,200
+25,600
+16% +$1.45M 0.02% 841
2015
Q3
$6.31M Buy
158,600
+4,400
+3% +$175K 0.01% 1106
2015
Q2
$7.37M Buy
154,200
+13,800
+10% +$659K 0.01% 1099
2015
Q1
$4.71M Hold
140,400
0.01% 1446
2014
Q4
$4.71M Buy
140,400
+36,900
+36% +$1.24M 0.01% 1446
2014
Q3
$1.62M Hold
103,500
﹤0.01% 2193
2014
Q2
$1.54M Hold
103,500
﹤0.01% 2272
2014
Q1
$1.46M Buy
103,500
+4,900
+5% +$68.9K ﹤0.01% 2285
2013
Q4
$928K Sell
98,600
-155
-0.2% -$1.46K ﹤0.01% 2618
2013
Q3
$1.12M Buy
98,755
+23,200
+31% +$263K ﹤0.01% 2320
2013
Q2
$1.01M Buy
+75,555
New +$1.01M ﹤0.01% 2253